The global varicella zoster infection treatment market is witnessing steady expansion driven by increasing prevalence of herpes zoster (shingles), rising geriatric population, and improved awareness regarding early diagnosis and antiviral therapies. According to industry analysis, the market was valued at US$ 2.07 billion in 2024 and is projected to reach US$ 3.03 billion by 2031, growing...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek